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Abstract 
 
Over the recent decade, attention have been focused on the pathologic role of free radicals in a variety of diseases, which 
are most related to carcinogenesis process. Carcinogenesis is a multi-step process that is induced primarily by 
carcinogens leading to the development of cancer. Extensive research in the last few years has revealed that regular 
consumption of certain fruits and vegetables can reduce the risk of acquiring specific cancers. Catechins are 
phytochemical compounds found in high concentrations in a variety of plant-based foods and beverages. Studies with 
cell lines have demonstrated that catechins affect signal transduction pathways, inhibit cell proliferation and induce 
apoptosis. More mechanistic studies in these areas will help us to understand the inhibitory action of catechin against 
carcinogenesis and provide background for evaluating the effects of catechin on human carcinogenesis. 
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Abstrak 
 
Selama beberapa dekade terakhir, perhatian telah difokuskan pada peran patologis radikal bebas dalam berbagai 
penyakit, yang paling banyak terkait dengan proses karsinogenesis. Karsinogenesis adalah proses multi-step yang paling 
banyak diinduksi oleh karsinogen yang mengarah ke perkembangan kanker. Penelitian yang meluas dalam beberapa 
tahun terakhirmengungkapkan bahwa konsumsi buah dan sayuran secara teratur dapat mengurangi risiko timbulnya 
kanker tertentu. Katekin adalah senyawa biokimia yang ditemukan dalam konsentrasi tinggi dalam berbagai makanan 
dan minuman nabati. Penelitian dengan menggunakan galur sel telah menunjukkan bahwa katekin mempengaruhi jalur 
transduksi sinyal, menghambat proliferasi sel, dan menginduksi apoptosis. Semakin banyak penelitian tentang 
mekanisme ini dilakukan, maka  akan membantu kita untuk memahami aksi hambatan katekin terhadap karsinogenesis 
dan memberikan latar belakang dalam mengevaluasi efek katekin terhadap karsinogenesis manusia. 
 
Kata kunci: Katekin, Karsinogenesis, Pencegahan kanker 
 
 
INTRODUCTION 
 
Tumorigenesis is a multistep process that begins 
with cellular transformation, progresses to hyperpro-
liferation and culminates in the acquisition of inva-
sive potential, angiogenic properties and establish-
ment ofmetastatic lesions. This process can be act-
ivated by any one of the various environmental car-
cinogens (such as cigarette smoke, industrial emis-
sions, gasoline vapours), inflammatory agents (such 
as tumour necrosis factor and H2O2), tumour pro-
moters (such as phorbol esters and okadaic acid). 
This multistep process of carcinogenesis consists of 
three phases: tumour initiation, promotion, and pro-
gression phases.
1
 Carcinogenesis is characterized by 
uncontrolled cell growth and acquisition of metas-
tatic properties. In most cases, activation of onco-
genes and/or deactivation of tumour suppressor 
genes lead to uncontrolled cell cycle progression and 
inactivation of apoptotic mechanisms.
2
 
Chemoprevention, especially through the use of 
naturally occurring phytochemicals capable of im-
peding the process of carcinogenesis at one or more 
steps, is an ideal approach for cancer management.
3
 
Cancer chemoprevention, by the use of natural, die-
tary orsynthetic agents that can reverse, suppress or 
prevent carcinogenic progression, has become an ap-
pealing strategy to combat the dogma associated 
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with increasing cases of cancers worldwide.
4
 Exten-
sive research in the last few years has revealed that 
regular consumption of certain fruits and vegetables 
can reduce the risk of acquiring specific cancers. 
Phytochemicals derived from such fruits and vege-
tables, referred to as chemo preventive agents in-
clude genistein,  resveratrol, diallyl sulfide, S-allyl 
cysteine, allicin, lycopene, capsaicin, curcumin, 6-
gingerol, ellagic acid, ursolic acid, silymarin, 
catechins, and eugenol.
5
 One of the phytochemical 
compounds that currently have an important role as 
an antioxidant is catechins. Catechins are a group of 
polyphenolic compounds belonging to flavonoid 
class present in high concentrations in a variety of 
plant-based fruits, vegetables, and beverages.
6
 Many 
research articles have established that in vitro studies 
of catechins have the potential to impact a variety of 
human diseases.
7
 The beneficial effect of catechins is 
reported in the treatment of cancer, cardiovascular 
diseases, diabetes, neurodegenerative diseases, and 
liver diseases.
8
 Apparently, catechins have function 
not only as powerful antioxidant,
9
 preventing oxi-
dative damage in healthy cells,
10
 but also as an anti-
angiogenic, antitumor agent,
11
 and a modulator of 
tumor cell response to chemotherapy.
12
 It can induce 
apoptosis by increasing caspases
13
 and promotes cell 
growth arrest by altering the expression of cell cycle 
regulatory proteins.
14
 This review describes the mo-
lecular mechanism of catechins as a non-toxic na-
tural agent in preventing the tumour progression and 
/or treatment of human malignancies. 
Sources and structure of catechins Polyphenols are 
the most abundant antioxidants in our diets. The 
main classes ofpolyphenols are phenolic acids 
(mainly caffeic acid) and flavonoids (the most abun-
dant in the diet areflavanols (catechins plus proan-
thocyanidins), anthocyanins and their oxidation pro-
ducts), which account for one- and two-thirds, res-
pectively.
15
 Catechins are the main flavanols, which 
are very abundant in tea. Young shoots contain 200–
340 mgof catechin, gallocatechin and their galloy-
lated derivatives per gram of dry leaves.
15
 Frequent 
consumption of tea, an important source of both fla-
vanols and flavonols, has been correlated with a lo-
wer incidence of cancer of the breast, prostate, blad-
der, lung, pancreas, colon, stomach, oesophagus, and 
oral cavity.
16
 
The term catechins are commonly used to refer the 
family of flavonoids and the subgroup flavan-3-ols 
or simply, flavanol. Catechins are differentiated from 
the ketone-containing flavonoids such as quercetin 
and rutin, which are called flavonols. High concen-
trations of catechin can be found in fresh tea leaves, 
red wine, broad beans, black grapes, apricots, and 
strawberries.
6
 Green tea has attracted significant 
attention recently, both in the scientific and in consu-
mer communities for its health benefits for a variety 
of disorders, ranging from cancer to weight loss. The 
beneficial effects of green tea are attributed to the 
polyphenolic compounds present in green tea, parti-
cularly the catechins, which make up 30% of the dry 
weight of green tea leaves.
17
 Also, epicatechin con-
centrations are high in apples, blackberries, broad 
beans, cherries, black grapes, pears, raspberries, and 
chocolate (Table. 1). 
 
Table 1. Sources of catechin widely distributed in food
6 
 
Food Catechins 
(mg/100g) 
Catechins              
(mg/serving) 
Apple 10-43 20-86 
Apricot 10-25 20-50 
Beans 35-55 70-110 
Black tea 6-50 12-100 
Blackberry 9-11 9-11 
Cherry 5-22 10-44 
Chocolate 46-61 23-30 
Cider 4 8 
Grape 3-17.5 6-35 
Green tea 10-80 20-160 
Peach 5-14 10-28 
Red raspberry 2-48 2-48 
Red wine 8-30 8-30 
Strawberry 2-50 2-50 
 
Apples contain a variety of polyphenols including 
quercetin, catechin, phloridzin and chlorogenic acid, 
all of which are strong antioxidants. Strawberries 
were found to contain the most complex mixture of 
catechins, comprising catechin (75% of total cate-
chins), (−) epicatechin-3-gallate (ECG) 18% of total 
catechins, (−) epigallocatechin (EGC) 5% of total 
catechins, and(+) gallocatechin (GC) 3% of total ca-
techins.
18 There are many vegetables, which are 
good sources of catechins. Catechins and type B pro-
cyanidins have not been found in leafy greens or root 
vegetables but have been detected in legumes such 
as broad and green beans. The beneficial effects of 
green tea are attributed to the polyphenolic com-
pounds present in green tea, particularly the cate-
chins, which make up 30% of the dry weight of 
green tea leaves.
19 Catechins are the major building 
blocks of tannins when they join, they are also 
known as procyanidins. These compounds are most 
common in the seeds and skins of grapes that have 
not fully ripened.
20 There are several polyphenolic 
catechins in green tea, viz. (−) epicatechin (EC), 
ECG, EGC, (−) epigallocatechin-3-gallate (EGCG), 
(+) catechin, and GC (Figure 1.).
17
 EGCG, the most 
abundant catechin in green tea, accounts for 65% of 
the totalcatechin content. A cup of green tea may
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contain 100–200 mgof EGCG. Catechin and gallo-
catechin are present in traceamounts. Most of the 
medicinal properties of green tea are associated with 
the epicatechins(2R, 3R) rather than the catechins 
(2S, 3R). 
 
 
 
Figure 1. Structures of the major polyphenolic catechins present in green tea.
6
 
 
It is well known that oncogene mutation and re-
active oxygen species (ROS) play important roles in 
the cancer initiation stage. Oncogene mutation leads 
to procarcinogen activation by activating some phase 
I enzymes such as the cytochrome P450s. ROS ac-
tively participate in the metabolic activation of pro-
carcinogens. EGCG can neutralize these procarci-
nogens by inhibiting the activity of cytochrome 
P450 enzymes and modulating ROS. Initiation pha-
se, catechins are able to neutralize the procarci-
nogens by inhibiting the activity of cytochrome 
P450 enzyme and modulating free radicals.
21 Wang 
et al. proved that catechins were able to inhibit the 
activity of Nicotinamide adenine dinucleotide phos-
phate (NADPH)-cytochrome  c reductase. Mukhtar 
et al. also claimed that EGCG could interact with he-
patic cytochrome P450 and inhibit the P450-depen-
dent mixed-function oxidase enzymes in skin and 
liver.
22 The epicatechin derivative structure is capa-
ble in inhibiting microsomal enzyme system derived 
from the catechin hydroxyl group.
23
 The pyrogallol 
structure causes catechin molecules to have a strong 
metal-chelating ability that can bind to metal transi-
tion ions and act as preventive antioxidants. Its high 
affinity for the two layers of lipid cell membrane 
makes it easier for catechin molecules to enter the 
nucleus of cancer cells.
23
 
The initiation and progression of cancer are related 
to epigenetic alterations, including aberrant DNA 
methylation and acetylation. Cancer is modulated by 
both genetic and epigenetic events. Epigenetic 
events could alter gene expression without changing 
the primary DNA sequence, and epigenetic mecha-
nisms include DNA methylation and histone ace-
tylation. These epigenetic changes are involved in 
the alteration of gene function and expression, lea-
ding to a malignant cellular formation. Among vari-
ous epigenetic modifications, DNA methylationis 
most extensively studied in mammals.
24
 Hyperme-
thylation on the DNA molecule limits the binding of 
transcription factors to promoters, resulting in the re-
cruitment of additional silencing-associated proteins 
and gene silencing. This methylation is mediated by 
DNA methyltransferase (DNMT).
24
 EGCG has been 
known as an inhibitor of DNMT by direct inhibitory 
interaction with the catalytic site of DNMT. The 
EGCG increases levels of acetylation on lysine of 
histone H3 and histoneH4, leading to the up regu-
lation of tumor-suppressor genes,p16INK4a, and 
Cip1/p21 in skin carcinoma cells.
25
 
ROSs are critical signalling molecules that modu-
late anticancer effects. First, EGCG could directly 
scavenge ROS. The antioxidant activity of EGCG 
results from the transfer of hydrogen atom or single-
electron transfer reactions, involving hydroxyl 
groups of the B and/or D rings. The antioxidant 
effect of EGCG is related to anticancer function. The 
EGCG reduces cell proliferation and induces apop-
tosis in low-dose H2O2 (10M)-treated colon carci-
nomacells and down regulates 12-O-tetradecanoyl-
phorbol-13-acetate-mediated oxidative stress in 
cervical carcinomacells.
26
 
The cancer promotion stage is a reversible and a 
long-term process, in which some intracellular sig-
nalling pathways and proteins associated with cell 
cycle are involved. EGCG exerts its anticancer effect 
by interfering with many signalling pathways and 
modulating cell cycle. The inhibitory mechanism of 
the promotion stage is divided into three process, 
namely the intervention of intracellular signalling 
pathways, increases the caspase activity, and cell 
cycle modulation. Yamamoto et al. showed that ca-
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techins inhibit phosphorylation of extracellular sig-
nal-regulated protein kinases (ERK)-1 and 2 and 
suppress the activity of p38MAPKs in human fibro-
sarcoma cells.
27
 The ERK enzymes are important 
transducers of proliferation signals.
27
 Alshatwi eva-
luated the role of catechin hydrate (CH) in suppres-
sing proliferation of MCF-7 cells through TP53/ 
caspase mediated apoptosis.
28 CH exhibits anticancer 
effects by blocking the proliferation of MCF7cells 
and inducing apoptosis in part by modulating ex-
pression levels of caspase-3, -8, and -9 and p53.
28
 
The induction of apoptosis by CH is affected by its 
ability to regulate the expression of pro-apoptotic 
genes such ascaspase-3, -8, and -9 and p53.
28
 Naka-
zato et al. found that (-)-Epigallocatechin-3-gallate 
has potential as a novel therapeutic agent for patients 
with B-cell malignancies including multiple mye-
loma via induction of apoptosis mediated by modi-
fication of the redox system. In addition, (-)-epigal-
locatechin-3-gallate enhanced As 2O3 – induced  
apoptosis in human multiple myeloma cells.
29
 Most 
an-ticancer agents have been reported to kill tumour 
cells by inducing apoptosis via the mitochondrial 
apoptotic pathway, or via the death receptors. Apop-
tosis has been known as a key strategy for the elimi-
nation of cancer cells. The ratio between anti-apop-
totic Bcl-2families (Bcl-2 and Bcl-xL) and proa-
poptotic Bcl-2 families(Bax and Bak) decides the 
cellular susceptibility against anticancer drugs in 
cancer cells. Furthermore, BH3-only proteins (PU-
MA, Noxa, and Bim) bind with anti-Bcl-2 proteins 
to inhibit their functions, resulting in induction of 
apoptosis. EGCG induces apoptosis by the-down-
regulation of Bcl-2 and/or up-regulation of Bax ex-
pression in nasopharyngeal carcinoma cells.
30 How-
ever, another research found that catechin, parti-
cularly EGCG, did not modulate the apoptotic path-
way, but predominantly induced caspase-indepen-
dent cell death in accordancewith the necrotic 
morphology.
13
 The EGCG induced necroticcell 
death via a caspase-independent mechanism in chro-
nic myelogenous leukemia (CML) celllines, without 
influencing any aspects of the apoptotic pathway.
13
 
Katunuma et al. reported that the tea-catechin de-
rivatives are shown to inhibit activities of caspases-3, 
2 and 7 in vitro, and prevented experiment ala-
poptosis at the cell and animal levels. Epigallo-
catechin-gallateshowed the strongest inhibition to 
these caspases, but cysteine cathepsins and caspase-8 
were not inhibited.
31
 
Catechins can also inhibit the cell cycle. The cell 
cycle is controlled by numerous mechanisms ensu-
ring correct cell division.
32 The mechanisms are 
regulation of cyclin-dependentkinases (CDK) by cy-
clins, CDK inhibitors and phosphorylating events.
32 
Cell-cycle dysregulation is a hallmark of tumor cells. 
The ability of normal cells to undergo cell-cycle ar-
rest after damage to DNA is crucial for the mainte-
nance of genomicintegrity.
33
 The biochemical path-
ways that stop the cellcycle in response to cellular 
stressors are called checkpoints. Defective check-
point function results in genetic modifications that 
contribute to tumorigenesis. The regulation of check-
point signalling also has important clinical imply-
cations because the abrogation of checkpoint func-
tion can alter the sensitivity of tumour cells to che-
motherapeutics. Mayr et al. evaluated the cytotoxic 
effect of EGCG alone or in combination with cispla-
tin on eight BTC cell lines. The EGCG reduced the 
mRNA levels of various cell cycle-related genes 
while increasing the expression of the cell cycle inhi-
bitor p21 and the apoptosis-related death receptor 
5.
34 This observation was accompanied by an in-
crease in caspase activity and cells in thesub-G1 pha-
se of the cell cycle, indicating induction of apoptosis. 
EGCG also induced a down-regulation of expression 
of stem cell-related genes and genes that are asso-
ciated with an aggressive clinical character of the 
tumour, such ascd133 and abcg2.
34
 The function of 
catechin is also related to cell cycle modulation in 
the cancer cell. Nihal et al. showed that catechins can 
inhibit Cdk1 and Cdk2 activities as well as CKI 
initiation such as p16, p21, and p27 in melanoma.
35 
Kavanagh et al. found that p27 capable of stopping 
in the G1/S phase could be induced by catechins in 
breast cancer.
36
 Another study reported by Hastak et 
al. showed that catechins were able to block the cell 
cycle, especially in the dependent p53 pathway 
which involved the function of p21 and Bax in pros-
tate carcinoma cells.
37
 Mayr et al. reported a 
reduction in regulatory genes triggering cell cycle 
such as ccna2, ccnbl, cendl, and e2fl due to catechin 
administration, whereas p21 expression which was a 
cell cycle inhibitor and also dr5 gene associated with 
apoptosis increased.
34
 This condition affected 
mRNA expression followed by increased activity 
caspase, subG1 population (an indication of apop-
tosis), decrease in population G2//M (an indication of 
cell cycle arrest) in bladder cancer cells.
34
 
Carcinogenesis involves uncontrolled cell growth, 
which follows the activation of oncogenes and/or the 
deactivation of tumour suppression genes. Metas-
tasis requires down-regulation of cell adhesion re-
ceptors necessary for tissue-specific, cell-cell attach-
ment, as well as up-regulation of receptors that en-
hance cell motility.Inhibition of migration and inva-
sion of tumor cells could be a target of anticancer 
therapy. Catechin resistance at the stage of cancer 
progression is its role in inhibiting MMP. This en-
zyme is a protease that can degrade almost all com-
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ponents of the extracellular matrix. Catechins are 
able to inhibit MMP-2 and MMP-9 in endothelial 
cells.
38
MMP-2 and MMP-9 secretion is elevated in 
several types of human cancers and their elevated 
expression has been associated with poor prognosis. 
Expression of MMPs is highly regulated by cyto-
kines and signal transduction pathways, including 
those activated by phorbol 12-myristate 13-acetate 
(PMA).38 
Angiogenesis, the development of new capillaries 
from pre-existing blood vessels, is required in phy-
siological processes such as wound healing and 
pathological conditions including tumour growth 
and metastases. Tumour angiogenesis is a complex 
process that consists of several steps including the 
secretion of angiogenic factors by tumour and host 
cells, activation of proteolytic enzymes, endothelial 
cell migration, invasion, endothelial cell prolifera-
tion, and capillary formation. Vascular endothelial 
growth factor (VEGF) and its receptors have been 
known as the important angiogenic factors and are 
commonly over expressed in several types of human 
cancers. Catechins especially EGCG is proved to 
inhibit tumour growth and angiogenesis by the 
down-regulation of VEGF expression in serum-
deprived HT29 human colon cancer cells.
39
 Leong et 
al. also found that green tea extract inhibits angio-
genesis partly through the disruption of STAT3-me-
diated transcription of genes, including VEGF.
40 
Several members of the signal transducers and acti-
vators of transcription (STAT) family play a role in 
tumorigenesis. The STAT3 activity is commonly up-
regulated in breast cancer and regulates the expres-
sion of angiogenic genes including VEGF and MM-
P9.
40
 
 
CONCLUSION 
 
This review presents evidence that catechins can 
be used not just to prevent cancer but also to treat 
cancer because of their effects in the initiation, pro-
motion, and progression stages. Catechins, especial-
ly EGCG promotes anticancer effects by modulation 
of multiple processes, including inhibition of carci-
nogen activity, tumorigenesis, proliferation, apop-
tosis induction, cell cycle arrest, metastasis, and 
angiogenesis. Based on the molecular mechanisms 
of the EGCG-induced anti-cancer effect, further 
studies are needed to define the use of catechins in 
clinical treatment. 
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